Merck KGaA, a global pharmaceutical and chemical company, and Millipore Corporation , a leading Life Science company based in Billerica, Massachusetts, USA, today announced that they have entered into a definitive agreement under which Merck KGaA will acquire all outstanding shares of common stock of Millipore, for US$ 107 per share in cash, or a total transaction value, including net debt, of approximately EUR 5.3 billion . Read Original Post Here

This entry was posted on Sunday, February 28th, 2010 at 10:33 pm and is filed under M & A. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.